## **Core Concept**
The question requires knowledge of the management of severe contact dermatitis, particularly in a patient with comorbidities such as uncontrolled diabetes mellitus and hypertension. The treatment of contact dermatitis often involves topical corticosteroids, but severe cases may necessitate systemic therapy. The patient's comorbid conditions are crucial in selecting a systemic agent.

## **Why the Correct Answer is Right**
The correct answer, , is likely a corticosteroid. Corticosteroids are potent anti-inflammatory agents effective in treating severe contact dermatitis. They can be used topically for mild to moderate cases but are often required systemically for severe reactions. In a patient with uncontrolled diabetes and hypertension, careful consideration of the side effects of systemic corticosteroids, such as hyperglycemia and hypertension exacerbation, is necessary. However, for severe dermatitis, the benefits may outweigh the risks, especially if used for a limited duration.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option could potentially be another class of drugs used in treating dermatitis, such as antihistamines or non-steroidal anti-inflammatory drugs (NSAIDs), which are less effective for severe contact dermatitis.
- **Option B:** This might represent a topical agent or another systemic medication not ideal for severe contact dermatitis, especially if it does not provide sufficient potency for a severe reaction.
- **Option D:** This could be a less appropriate systemic agent for this case, possibly due to side effects, interactions with the patient's current medications, or reduced efficacy for severe contact dermatitis.

## **Clinical Pearl / High-Yield Fact**
In patients with severe contact dermatitis and comorbid conditions like diabetes and hypertension, **systemic corticosteroids** are effective but require careful monitoring. A short course may be necessary to control the dermatitis while attempting to manage the patient's other conditions. Always consider the risk-benefit ratio, especially in patients with significant comorbidities.

## **Correct Answer:** .